Zeev E. Neuwirth, MD
Advisor

Dr. Neuwirth was appointed Senior Medical Director of Population Health for the Carolinas Healthcare System (CHS) in November 2016. In this newly created position within CHS, he serves as the senior most physician responsible for advancing the system's value focused strategies.

Prior to this appointment, Dr. Neuwirth served as the Senior Medical Director for Primary Care Services within CHS, which proactively provides primary medical care to over 1.1 million patients, and serves a community of over 2 million people in the greater Charlotte area. He was responsible for leading the redesign of the Primary Care ecosystem at CHS and also served as an executive leader in Population Health, Care Management, Retail Care & Virtual Medicine. Prior to joining CHS, Zeev served as Chief of Clinical Effectiveness & Innovation at Harvard Vanguard Medical Associates, a 600 physician multi-specialty practice located in Eastern Massachusetts.

Dr. Neuwirth has over a decade of experience in quality improvement, care redesign & innovation. His efforts to improve and transform healthcare delivery have been featured in Forbes, Fast Company, WebMD, the Yale School of Management Journal, The Boston Globe, The Charlotte Observer, and in two Harvard Business School case studies.

In 2011, he was awarded the Boston Mayoral Award for Innovation in Healthcare. In 2012, he was selected as one of 70 participants, from a pool of over 1000 applicants, into the Center for Medicare & Medicaid Services (CMMS) Innovation Fellows program. In 2014, he received an 'Innovation in Healthcare' award from the Charlotte Business Journal.

Dr. Neuwirth is an alum of Tufts University and the University of Pennsylvania School of Medicine. He received a Masters in Healthcare Management from the Harvard School of Public Health, where he continues to lecture on healthcare strategy & innovation.

About Us

Virta is an online specialty medical clinic that is on a mission to reverse type 2 diabetes in 100 million people. Learn how we are rethinking this epidemic.